Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease. Ummenthum K, Peferoen LAN, Finardi A, Baker D, Pryce G, Mantovani A, Bsibsi M, Bottazzi B, Peferoen-Baert R, van der Valk P, et al. Eur J Immunol. 2015 Nov 18. PMID: 26576501. Abstract CommentRecommendBookmarkWatch